Abstract
Inclusion bodies (IBs) are typically non-functional particles of aggregated proteins. However, some proteins in fusion with amyloid-like peptides, viral coat proteins, and cellulose binding domains (CBDs) generate IB particles retaining the original functions in cells. Here, we attempted to generate CBD IBs displaying functional leucine zipper proteins (LZs) as bait for localizing cytosolic proteins in E. coli. When a red fluorescent protein was tested as a target protein, microscopic observations showed that the IBs red-fluoresced strongly. When different LZ pairs with KDs of 8–1,000 µM were tested as the bait and prey, the localization of the red fluorescence appeared to change following the affinities between the LZs, as observed by fluorescence imaging and flow cytometry. This result proposed that LZ-tagged CBD IBs can be applied as an in vivo matrix to entrap cytosolic proteins in E. coli while maintaining their original activities. In addition, easy detection of localization to IBs provides a unique platform for the engineering and analyses of protein-protein interactions in E. coli.
Introduction
Inclusion bodies (IBs) are dense, electron-refractile particles of aggregated proteins found in the cytoplasmic space of bacterial cells [1]. Hydrophobic heterologous proteins expressed at high levels in bacterial cells are likely to accumulate in IBs [2], [3]. IBs vary in diameter from 0.5–1.3 µm and are more dense (∼1.3 mg/mL) than many other cellular components, which make the particles easy to separate from disrupted cells by high-speed centrifugation for protein refolding [4], [5].
In general, the proteins in IBs are functionally inactive. However, recent studies have shown that they are not necessarily inactive, and some exhibit substantial levels of activity in E. coli [2], [3], [6]–[8]. For example, certain enzymes fused to a viral capsid protein or an ionic self-assembling peptide generated active IBs that had high levels of catalytic activity [6]–[8]. Accordingly, we found that a family II cellulose binding domain (CBD) from Cellulomonas fimi induced the formation of active IBs when fused with β-glycoside hydrolyzing enzymes. The enzymatic activity of these IBs was 30%–40% of that of the soluble enzymes [9]. In addition, a family IIIa CBD has also been used to form active IBs with high D-amino acid oxidase activity [10]. The family II CBD in IBs also exhibited significant binding affinity towards insoluble celluloses [9].
In this study, the family II CBD from C. fimi was used to generate IBs displaying functional leucine zipper proteins (LZs) as bait for localizing soluble cytosolic proteins in E. coli (Fig. 1A). LZs are universal, two-stranded, α-helical heterodimers that are found in diverse DNA binding proteins and dimerization domains [11], [12]. Therefore, the heterodimer formation between LZs was expected to recruit soluble, functionally active proteins to IBs (Fig. 1B). As a soluble model protein, monomeric red fluorescent protein 1 (mRFP1) [13] was used to allow for rapid and quantitative analysis in living cells. Imaging and flow cytometric analyses showed that protein localization increased according to the binding affinity between the LZ proteins, consistent with the observations of a report that showed that dimerization of coil proteins caused the co-purification of soluble enzymes in IB fractions [14]. Our affinity-based localization of cytosolic proteins to active IBs is expected to be useful for many biotechnology applications: for example, the in vivo matrix can be used to localize enzymes for sequential reactions to the same locations in cells, thereby adjusting the local concentration of the enzymes and reducing intermediate loss through diffusion and side reactions [15]–[17]. In addition, as the localization of interacting proteins to IBs can be easily identified, this study provided a new platform for investigating protein-protein interactions in living cells, using fluorescence microscopy or flow cytometry [18].
Materials and Methods
Materials
The family II CBD was cloned from the exoglucanase (cex) of Cellulomonas fimi KCTC 9143. The EGFP gene was obtained from the commercial plasmid pEGFP-N1 (Clontech, Mountain View, CA, USA). The pRFP plasmid, which contains the gene for monomeric red fluorescent protein 1 (mrfp) [13], was a kind gift from Dr. R. Tsien (UCSD, USA). Genes encoding two anti-parallel LZs, used for the bait and prey, were cloned from pET11a-Z-NGFP and pMRBAD-Z-CGFP [12], respectively, which were provided by Dr. L. Regan (Yale University, USA). E. coli DH5α (Takara Bio, Ohtsu, Japan) and BL21(DE3) (Novagen, Gibbstown, NJ, USA) cells were used as the cloning host and the expression host, respectively. All restriction enzymes were purchased from Roche Applied Science (Indianapolis, IN, USA), and T4 DNA Ligase was purchased from Fermentas (Glen Burnie, MD, USA).
DNA manipulation
All primers were synthesized by Bioneer Co. (Daejeon, Korea) (Table S1). The EGFP gene was amplified from pEGFP-N1, and then cloned into the NdeI and XhoI sites of pET21a (Invitrogen, Carlsbad, CA, USA) to yield pEGFP. The EGFP-CBD gene was prepared using overlap PCR and was inserted into the NdeI and HindIII sites of pET21a to yield plasmid pEGFP-CBD. The bait and prey LZs were fused to the EGFP-CBD and mRFP genes, respectively, by overlap extension PCR (Fig. S1). The resulting bait-EGFP-CBD and prey-mRFP genes were then inserted into pET21a to yield pCN20-CBD. pC20-CBD, a bait-less variant of pCN20-CBD was constructed by using EGFP-CBD instead of bait-EGFP-CBD. Four variants of the pCN20-CBD plasmid (pCN8-CBD, pCN31-CBD, pCN50-CBD, and pCN1000-CBD) were constructed by introducing known mutations into the prey moiety as shown in Table 1 [12], using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA, USA).
Table 1. Amino acid sequences and affinity information of mutant CZs.
No. | CZ peptide | Mutations | KD (µM) |
CN8-CBD | EQLKKKLQALEKKLAQLEWKNQALEKELAQ | 4/27 | 8 |
CN20-CBD | EQLEKKLQALEKKLAQLEWKNQALEKKLAQ | None | 20 |
CN31-CBD | EQLEKKLQALEKKLAQLEWKNQALKKKLAQ | 25 | 31 |
CN50-CBD | EQLEKKLQALKKKLAQLEWKNQALEKKLAQ | 11 | 50 |
CN1000-CBD | EQLEKKLQALEKELAQLEWKNQALKKELAQ | 13/25/27 | 1000 |
Mutation sites are underlined. The CZ peptide sequences and KD's were adopted from the results of Magliery TJ et al. [12].
Protein expression and western blotting analysis
E. coli BL21(DE3) cells were cultivated at 37°C in LB medium containing ampicillin (50 µg/mL). Protein expression was induced with 0.5 mM IPTG when the cultures reached an OD600 of 0.5, and the cells were incubated for an additional 6 h. The cells were harvested by centrifugation at 16,300×g for 10 min and then disrupted by sonication on ice.
The protein expression was analyzed by SDS-PAGE and western blotting. Aliquots of cell lysates were electrophoresed on 12% SDS-polyacrylamide gels and electro-transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). The membranes were hybridized with an anti-GFP mouse antibody (Sigma-Aldrich, St. Louis, MO, USA) and an anti-groEL antibody as the internal standard (Abcam, Cambridge, MA, USA), followed by an HRP-conjugated anti-mouse IgG goat antibody (Bio-Rad, Hercules, CA, USA) prepared in TBST buffer (20 mM Tris-HCl, 100 mM NaCl, and 0.1% Tween-20, pH 7.5) containing 5% skimmed milk. The hybridized bands were identified by colorimetric detection using an Opti-4CN substrate kit (Bio-Rad).
Imaging and fluorescence analyses
Cells were observed with an Axio Observer microscope (Carl Zeiss, Oberkochen, Germany) at ×1,000 magnification under differential interference contrast (DIC) imaging conditions. Fluorescence imaging was also performed using the same microscope fitted with a GFP filter (excitation BP 470/20, beam splitter FT 493, emission BP 505–530) and a rhodamine filter (excitation BP 546/12, beam splitter FT 580, emission LP 590) for EGFP and mRFP, respectively. Image acquisition and region-of-interest analyses were performed using MetaMorph software (Molecular Devices, Sunnyvale, CA, USA). At least 5 cells per image were selected and subjected to region-of-interest analyses. All ROI data were presented as means ± standard error of the mean.
Flow cytometry
Flow cytometric analyses were performed using a FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). The gate was set based on side scatter channel (SSC) and forward scatter channel (FSC) parameters, and the EGFP and mRFP signals were detected using FL1 (530/30 nm) and FL2 (585/42 nm) photomultiplier tubes (PMTs), respectively. The overlap of the EGFP and mRFP signals was minimized using a compensation option. A total of 104 cells were counted for each sample and the data were collected using BD CellQuest Pro software (version 4.0.2; BD Biosciences). Cell sorting was performed using a FACSAria Cell Sorter (BD Biosciences) at KRIBB, Jeonbuk Branch (Jeongeup, Korea).
Electron microscopy and Zeta-potential analysis
For SEM imaging, purified CBD-IBs were fixed in a mixture of 2.5% paraformaldehyde and 2.5% glutaraldehyde in a 100-mM sodium phosphate buffer (pH 7.2) for 2 h, post-fixed with 1% osmium tetroxide in the same buffer for 1 h, dehydrated in graded ethanol, substituted with isoamyl acetate, and then critical point dried in CO2. The samples were then coated with gold in a SC502 sputter coater (Quorum Technologies Ltd, East Sussex, UK) and observed under a Quanta 250 FEG scanning electron microscope (FEI, Hillsboro, OR, USA) at KRIBB (Daejeon, Korea).
The size and zeta-potential of the EGFP-IBs were measured using a Malvern Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) at the National Nanofab Center (Daejeon, Korea). The protein solution was diluted with 10 mM Tris-HCl (pH 8.0), and 0.75 mL of the diluted solution was added to disposable zetasizer cuvettes for the measurements. The experiments were performed in triplicate and the data were processed using Zetasizer Nano software (version 6.01; Malvern Instruments).
Results
Generation of functional IBs
The CBDs include three to four aromatic residues that are exposed to bulk liquid on the surface of the protein (http://www.pdb.org; PDB ID: 1exg) [19], which may cause rapid aggregation of the protein. As previously mentioned, C-terminal fusions of the family II CBD from C. fimi formed active IBs retaining 30%–40% of the original activity while maintaining the ability to bind insoluble celluloses [9]. In the current study, E. coli cells expressing a fusion of the CBD with EGFP exhibited one or two fluorescent IBs in microscopic images (Fig. 2A). When cells expressing either EGFP or EGFP-CBD were compared by flow cytometry, the fluorescence intensity of the EGFP-CBD cells was estimated to be 10%–20% of that in cells expressing soluble EGFP (Fig. S2), although the expression of both proteins (as detected by western blotting) was similar. When the EGFP-CBD cells were sonicated in Tris buffer (50 mM Tris-HCl, pH 8.0 and 200 mM NaCl) to break the IBs into smaller pieces, the fluorescence intensity increased up to 2 folds in proportion to the sonication time (Fig. 2B). Therefore, the IBs are estimated to contain higher amounts of properly folded/native-like protein than that observed in flow cytometry. The low detection of fluorescence in IBs is discussed further in the Discussion section.
Localization of soluble proteins to IBs
The possibility of active IBs as a matrix to recruit soluble cytosolic proteins was tested by displaying a bait LZ that can bind to prey LZs in cytosol (Figs. 1A and 1B). LZ is a super-secondary structure that generates adhesion forces between α-helices. A single LZ consists of multiple leucine residues at approximately 7-residue intervals, which forms an amphipathic alpha helix with a hydrophobic region on one side. This hydrophobic region provides an area for dimerization, allowing the motifs to combine. Therefore, fusion proteins tagged with prey LZs may form a two-stranded α-helical coiled-coil heterodimer with the bait LZ in active IBs (Fig. 1A). A monomeric red fluorescent protein 1 (mRFP1) was used as a model prey protein to take advantage of its easy detection in living cells. The bait-EGFP-CBD and prey-mRFP1 genes were cloned into pET21a in a polycistronic manner to balance the relative expression of the bait and prey. When these bait and prey proteins were co-expressed in E. coli cells, the red fluorescence was clearly localized to the IBs (lower row in Fig. 2C), whereas the red fluorescence remained dispersed in cells without the bait LZ (upper row in Fig. 2C), showing that localization was dependent on the bait LZ.
Next, the effect of LZ binding affinity was investigated using different combinations of LZs (shown in Table 1). The leucine residue is essential for duplex formation, whereas ionic interactions between oppositely charged residues affected binding affinity. We examined five different bait and prey pairs that were designed by Magliery et al. [12] with KD values of 8, 20, 31, 50, and 1,000 µM. As anticipated, more red fluorescence was observed to localize to the IBs when bait-prey pairs with smaller KD values were used for the co-expression experiments (Fig. 3). When region-of-interest (ROI) analysis was applied to the cellular images (Fig. 4A), red fluorescence in cytosol decreased as the prey-mRFP1 protein localized to the IBs. Consequently, the mean yield of localization to IBs, ROI2 vs. ROI1, was calculated from at least five single cell images and a high yield of 0.65 was estimated for CN8 (KD = 8 µM), which was nearly the same as the mean yield for EGFP-CBD (Fig. 4B). The yield for CN1000 (KD = 1,000 µM) was approximately 0.30. Therefore, the higher the affinity of the bait for the prey, the more prey-mRFP localized to the IBs. In all the experiments, the expression levels of the bait-EGFP-CBD and prey-mRFPs were similar (as shown by SDS-PAGE analyses) (Fig. S3).
The localization of red fluorescence to IBs was also investigated by flow cytometry. When the cytometric results were drawn on FL1 vs. FL2 dot plots, the mRFP intensity (FL2) decreased as the binding affinity increased (Fig. 5A), whereas the EGFP intensity (FL1) increased. For example, the mean intensity of mRFP for the CN8-CBD cell populations was about 40% of that for cells with no bait in the CBD IBs (Fig. 5B). This result was consistent with the microscopic observations in Fig. 4A.
Finally, we attempted to purify cells with IB-localized red fluorescence using a single cell sorter, the FACSAria. For this experiment, equal amounts of cells with (pCN20-CBD) and without bait (pC20-CBD) were mixed, and the specific cells within a predetermined gate (dashed areas in Fig. 5A) were recovered. The collected cells were then analyzed by western blotting using an anti-GFP antibody (Fig. 5C). Lanes 1 and 2 show the control bands for bait-EGFP-CBD and EGFP-CBD, respectively. Before sorting, both proteins were observed in the cells (lane 3), whereas after sorting, the band corresponding to bait-EGFP-CBD was enriched in the recovered cells (lane 4), indicating selective sorting of cells with red fluorescent IBs due to protein-protein interactions between the bait and prey LZs.
High physical stability of fluorescent IBs
The functional IB particles were extracted from the CN20-CBD cells and the C20-CBD cells by sonication and washed twice with a solution containing 0.5% Triton X-100 detergent in a Tris buffer (50 mM Tris-HCl, pH 8.0 and 200 mM NaCl). Microscopic observation showed that the CN20-CBD IBs contained both green and red fluorescent IB particles, while the bait-less C20-CBD IBs contained only green fluorescent IBs because the prey-mRFP was washed out (Fig. 6). Therefore, the interactions in the active IBs were highly specific and were maintained during sonication and washing.
The physical stability of the active IBs was investigated using a zeta potential analyzer (Zetasizer Nano). The particle size was approximately 0.45–0.5 µm in diameter and the zeta potentials were estimated at approximately −56.8 mV. Zeta potentials larger than ±40 indicate that colloidal particles are stable in solution, while particles with a zeta potential smaller than ±30 tend to coagulate or flocculate easily [20]. Therefore, the IB particles in this study remained physically stable under both in vivo and in vitro conditions.
Discussion
Synthetic biology, an emerging field, involves the design and construction of new genetic devices for use in research and industry [15], [21]. One successful device applied to metabolite production is the synthetic protein scaffold [16], [17]. When a heterologous or synthetic pathway is introduced, the host cell can suffer from flux imbalance, intermediate loss, and chemical toxicity [22]. Therefore, constructing synthetic scaffolds may improve the metabolite conversion rate by increasing the local enzyme concentration and reducing intermediate loss caused by diffusion or side reactions. In this regard, CBD IBs could be useful as a synthetic matrix in E. coli cells. The target proteins can be recruited to the synthetic IB matrix via bait and prey interactions between LZs (Fig. 1), which are a well-known domain consisting of only 30 amino acids. LZs such as E, K coil proteins have been used previously to immobilize active enzymes in polyhydroxybutyrate synthase IBs [14]. In this study, the affinities between LZs were controlled by changing the amino acid sequences. In addition, mRFP1 was used as a soluble target protein because it is easy to detect without cell disruption. Imaging and flow cytometric analyses showed that prey localization was dependent on the binding affinity between the bait and prey LZ proteins; the prey protein exhibited only marginal localization to the IBs when the KD of the LZs was 1,000 µM (Fig. 3); as the KD decreased, localization increased sharply and it reached a maximum level when the KD was 8 or 20 µM. Eventually, we established a quantitative method to evaluate the localization of cytosolic proteins to IBs in situ by using LZs with different affinities (Fig. 3), which provides useful implications for the generation of synthetic matrices with designed compositions.
Localization of EGFP to IBs resulted in a large decrease in the fluorescence signal compared to the signal for soluble EGFP (Fig. S2), which is approximately half of the activity retention observed for catalytic enzymes in a previous study. The fluorescence intensity increased 2-fold when the particles were broken into smaller pieces by sonication (Fig. 2B). Based on literature reviews and our results in Fig. S4, the reason for the decreased fluorescence in the IBs is thought to be related with the scattering of the excitation light by the highly refractile surfaces of the IB particles [23], [24] and/or a shortened fluorescence lifetime in the densely packed environment [25]. In general, IBs are more dense (∼1.3 mg/mL) than any other cellular component.
Investigations of protein-protein interactions (PPIs) are crucial in modern biological science research [26], and there is growing interest in the development of high throughput technologies [18], [27]. In the method developed here, proteins with different affinity of LZs localized to IBs were quantitatively analyzed in living cells using flow cytometry (Fig. 5), while the E, K coil proteins in IB fractions was detected by electrophoretic methods after cell disruption in previous study [14]. Therefore, the current method can be applied usefully for high throughput screening of PPI inhibitors, comparisons of interacting protein partners, and engineering binding affinities in bacterial cells.
Conclusions
Fluorescent proteins localized in IBs exhibited high intrinsic activity; however, their activity was somewhat suppressed when localized to IBs formed by fusion with the CBD from C. fimi exoglucanase. The signal intensity on microscopic images or in high throughput flow cytometry was dependent on the binding affinities of the interacting pairs. This controlled localization to IBs in living cells can be useful for the collective localization of cytosolic proteins in E. coli for sequential reactions. In addition, easy detection of protein localization to the IBs may provide a new platform for the rapid analyses of PPIs in bacterial cells.
Supporting Information
Funding Statement
This research was supported by grants from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031944), the Pioneer Research Program for Converging Technology (20110001745), Bio-industry Technology Development Program (No. 310006-5), the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Palmer I, Wingfield PT (2012) Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli . Curr Protoc Protein Sci Chapter 6: Unit6 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Carrio MM, Corchero JL, Villaverde A (1998) Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria. FEMS Microbiol Lett 169: 9–15. [DOI] [PubMed] [Google Scholar]
- 3. Villaverde A, Carrio MM (2003) Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol Lett 25: 1385–1395. [DOI] [PubMed] [Google Scholar]
- 4. Sabate R, de Groot NS, Ventura S (2010) Protein folding and aggregation in bacteria. Cell Mol Life Sci 67: 2695–2715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99: 303–310. [DOI] [PubMed] [Google Scholar]
- 6. Ventura S, Villaverde A (2006) Protein quality in bacterial inclusion bodies. Trends Biotechnol 24: 179–185. [DOI] [PubMed] [Google Scholar]
- 7. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, et al. (2005) Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 4: 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Wu W, Xing L, Zhou B, Lin Z (2011) Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli . Microb Cell Fact 10: 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Choi S-L, Lee SJ, Ha J-S, Song JJ, Rhee YH, et al. (2011) Generation of catalytic protein particles in Escherichia coli cells using the cellulose-binding domain from Cellulomonas fimi as a fusion partner. Biotechnol Bioprocess Eng 16: 1173–1179. [Google Scholar]
- 10. Nahalka J, Nidetzky B (2007) Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilis D-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng 97: 454–461. [DOI] [PubMed] [Google Scholar]
- 11. Ghosh I, Hamilton AD, Regan L (2000) Antiparallel leucine zipper-directed protein reassembly: application to the green fluorescent protein. J Am Chem Soc 122: 5658–5659. [Google Scholar]
- 12. Magliery TJ, Wilson CG, Pan W, Mishler D, Ghosh I, et al. (2005) Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: scope and mechanism. J Am Chem Soc 127: 146–157. [DOI] [PubMed] [Google Scholar]
- 13. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, et al. (2002) A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 99: 7877–7882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Steinmann B, Christmann A, Heiseler T, Fritz J, Kolmar H (2010) In vivo enzyme immobilization by inclusion body display. Appl Environ Microbiol 76: 5563–5569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Chen AH, Silver PA (2012) Designing biological compartmentalization. Trends Cell Biol 22: 662–670. [DOI] [PubMed] [Google Scholar]
- 16. Dueber JE, Wu GC, Malmirchegini GR, Moon TS, Petzold CJ, et al. (2009) Synthetic protein scaffolds provide modular control over metabolic flux. Nat Biotechnol 27: 753–759. [DOI] [PubMed] [Google Scholar]
- 17. You C, Zhang YH (2013) Self-assembly of synthetic metabolons through synthetic protein scaffolds: one-step purification, co-immobilization, and substrate channeling. ACS Synth Biol 2: 102–110. [DOI] [PubMed] [Google Scholar]
- 18. Koyama-Honda I, Ritchie K, Fujiwara T, Iino R, Murakoshi H, et al. (2005) Fluorescence imaging for monitoring the colocalization of two single molecules in living cells. Biophys J 88: 2126–2136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. McLean BW, Bray MR, Boraston AB, Gilkes NR, Haynes CA, et al. (2000) Analysis of binding of the family 2a carbohydrate-binding module from Cellulomonas fimi xylanase 10A to cellulose: specificity and identification of functionally important amino acid residues. Protein Eng 13: 801–809. [DOI] [PubMed] [Google Scholar]
- 20. Hanaor D, Michelazzi M, Leonelli C, Sorrell CC (2012) The effects of carboxylic acids on the aqueous dispersion and electrophoretic deposition of ZrO2. J Eur Ceram Soc 32: 235–244. [Google Scholar]
- 21. Khalil AS, Collins JJ (2010) Synthetic biology: applications come of age. Nat Rev Genet 11: 367–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Bentley WE, Mirjalili N, Andersen DC, Davis RH, Kompala DS (1990) Plasmid-encoded protein: the principal factor in the “metabolic burden” associated with recombinant bacteria. Biotechnol Bioeng 35: 668–681. [DOI] [PubMed] [Google Scholar]
- 23. Young PA, Clendenon SG, Byars JM, Dunn KW (2011) The effects of refractive index heterogeneity within kidney tissue on multiphoton fluorescence excitation microscopy. J Microsc 242: 148–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Theer P, Denk W (2006) On the fundamental imaging-depth limit in two-photon microscopy. J Opt Soc Am A Opt Image Sci Vis 23: 3139–3149. [DOI] [PubMed] [Google Scholar]
- 25. Suhling K, Siegel J, Phillips D, French PM, Leveque-Fort S, et al. (2002) Imaging the environment of green fluorescent protein. Biophys J 83: 3589–3595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Phizicky EM, Fields S (1995) Protein-protein interactions: methods for detection and analysis. Microbiol Rev 59: 94–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Lalonde S, Ehrhardt DW, Loque D, Chen J, Rhee SY, et al. (2008) Molecular and cellular approaches for the detection of protein-protein interactions: latest techniques and current limitations. Plant J 53: 610–635. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.